This page is maintained by Cristina Muñoz-Pinedo, from the Cell Death and Metabolism group, part of the Oncobell program at IDIBELL, Barcelona.
For a list of publications please check: ResearcherID or search Pubmed (Munoz-Pinedo) for the most recent ones.
Research lines:
• Molecular mechanisms of apoptosis and other forms of cell death induced by glucose deprivation and ischaemia
• Metabolic vulnerabilities in lung cancer and sarcoma
• Tumour microenvironment in cancers of the lung
Current research topics:
Our lab is interested in the regulation of apoptosis by the glycolytic metabolism, and its aplication to cancer therapy. In particular, we are studying how inhibition of glycolysis triggers apoptosis and autophagy in tumors, and how inhibitors of glucose uptake sensitize tumor cells to chemotherapy. We are also studying the role of endoplasmic reticulum stress and the Integrated Stress Response in apoptosis and necrosis induced by glucose deprivation and ischemia, and in interactions of the tumor cells with the microenvironment and the immune system
Team:
Fedra Luciano Mateo, Postdoctoral researcher
Miguel Hernández Madrigal, PhD student (predoc)
Francesca Favaro, PhD student (predoc)
Joaquim Moreno Caceres, Project Manager
* If you’re interested in a master, PhD or postdoctoral position in our lab, please contact me.
Thanks for notifying me of follow-up comments via email
Thanks for providing such a benefecial blog.
Hello Cristina,
Could you please share our most recent publication that details the outcome of our pre-clinical trial that tests mono-therapies and combinations therapies for ability to inhibit development of spontaneous breast cancer in a GEM model that is hyperactive for mTOR and cancer cell metabolism.
Thank you.
Paola
Oncotarget November 25, 2014.
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2818&path%5B%5D=5347
Muchas gracias, por añadirme al grupo, y por no poner mi nombre al revés.
Para mi fue un placer conoceros. Lo pase muy bien.
Ibo